2/17/2010

U.S. clinicians, so far, have been able to cope with the ongoing medical isotope shortage through various strategies, but many say they are worried that the situation will worsen when a Dutch reactor shuts down later this month for repairs. Combined medical isotope production at the reactors in Belgium, France and South Africa will be between 30% and 40% of normal total production while the Dutch and Canadian reactors are offline, estimates Robert Atcher, SNM past-president and isotope committee chairman.

Related Summaries